Literature DB >> 3904729

Affinity purification and refined structural characterization of terminal deoxynucleotidyltransferase.

S A Fuller, A Philips, M S Coleman.   

Abstract

A total of 56 stable murine hybridoma monoclones that produce homogeneous antibodies against human or calf terminal deoxynucleotidyltransferase have been established. All of the antibodies exhibited specific binding to various Mr forms of terminal transferase and eight possessed neutralizing activity. Results are presented that permitted characterization of ten of these antibodies with respect to their immunoglobulin class, their recognition of calf or human terminal-transferase Mr species by immunoblotting techniques and their recognition of distinct antigenic sites. Terminal transferase was purified in a single step by using an immunoaffinity column constructed with a monoclonal antibody exhibiting a high binding affinity for the enzyme. Single monoclonal antibodies were also used to bind selectively to terminal-transferase antigen in tissue slices and individual cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3904729      PMCID: PMC1152709          DOI: 10.1042/bj2310105

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  Development of terminal deoxynucleotidyl transferase activity in embryonic calf thymus gland.

Authors:  L M Chang
Journal:  Biochem Biophys Res Commun       Date:  1971-07-02       Impact factor: 3.575

2.  Terminal deoxynucleotidyltransferase. Alignment of alpha- and beta-subunits of the core enzyme along the primary translation product.

Authors:  C M Beach; S K Chan; T C Vanaman; M S Coleman
Journal:  Biochem J       Date:  1985-05-01       Impact factor: 3.857

3.  Proteolytic degradation of calf thymus terminal deoxynucleotidyl transferase.

Authors:  L M Chang; P Plevani; F J Bollum
Journal:  J Biol Chem       Date:  1982-05-25       Impact factor: 5.157

4.  Biochemistry of terminal deoxynucleotidyl transferase. Conditions for and characterization of ultraviolet light mediated substrate cross-linking to terminal deoxynucleotidyl transferase.

Authors:  M J Modak; E Gillerman-Cox
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

5.  Evaluation of methods of detecting terminal deoxynucleotidyl transferase in human hematologic malignancies. Comparison of immunofluorescence and enzymatic assays.

Authors:  M L Cibull; M S Coleman; O Nelson; J J Hutton; D Gordon; F J Bollum
Journal:  Am J Clin Pathol       Date:  1982-04       Impact factor: 2.493

6.  Molecular cloning of human terminal deoxynucleotidyltransferase.

Authors:  R C Peterson; L C Cheung; R J Mattaliano; L M Chang; F J Bollum
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

7.  Clonal proliferation unlinked to terminal deoxynucleotidyl transferase synthesis in thymocytes of young mice.

Authors:  E Rothenberg; D Triglia
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

8.  Unusual immunofluorescence patterns for terminal deoxynucleotidyl transferase in blast crisis chronic myelogenous leukemia.

Authors:  M L Cibull; M S Coleman; J J Hutton; F J Bollum; D V Jackson
Journal:  Am J Clin Pathol       Date:  1981-03       Impact factor: 2.493

9.  A new solid-phase immunoassay for terminal deoxynucleotidyl transferase: analysis of TdT antigen in cells, plasma, and serum.

Authors:  M S Coleman; M L Cibull; G L Manderino
Journal:  Blood       Date:  1985-01       Impact factor: 22.113

Review 10.  Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.

Authors:  M F Greaves
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

View more
  1 in total

1.  Association of terminal deoxynucleotidyl transferase with Ku.

Authors:  K N Mahajan; L Gangi-Peterson; D H Sorscher; J Wang; K N Gathy; N P Mahajan; W H Reeves; B S Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.